(Q30673059)

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

A short echo proton magnetic resonance spectroscopy study of the left mesial-temporal lobe in first-onset schizophrenic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

A short echo 1H spectroscopy and volumetric MRI study of the corpus striatum in patients with obsessive-compulsive disorder and comparison subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Altered development of prefrontal neurons in rhesus monkeys with neonatal mesial temporo-limbic lesions: a proton magnetic resonance spectroscopic imaging study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Brain pharmacokinetics and tissue distribution in vivo of fluvoxamine and fluoxetine by fluorine magnetic resonance spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Magnetic resonance spectroscopy. Bridging the neurochemistry and neuroanatomy of schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Selective Relationship Between PrefrontalN-Acetylaspartate Measures and Negative Symptoms in Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Proton magnetic resonance spectroscopy in the frontal and temporal lobes of neuroleptic naive patients with schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Brain choline in depression: in vivo detection of potential pharmacodynamic effects of antidepressant therapy using hydrogen localized spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Quantitation of dexfenfluramine/d-norfenfluramine concentration in primate brain using 19F NMR spectroscopy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Proton magnetic resonance spectroscopy of human basal ganglia: response to cocaine administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Abnormal cerebral metabolism in polydrug abusers during early withdrawal: a 31P MR spectroscopy study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Measurement of human brain dexfenfluramine concentration by 19F magnetic resonance spectroscopy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Two-dimensional proton echo-planar spectroscopic imaging of brain metabolic changes during lactate-induced panic.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Preliminary application of magnetic resonance spectroscopy to investigate lactate-induced panic.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Proton magnetic resonance spectroscopy investigation of hyperventilation in subjects with panic disorder and comparison subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Decreased anterior cingulate myo-inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

N-Acetylaspartate concentration in the anterior cingulate of maltreated children and adolescents with PTSD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Brain perfusion abnormalities in drug-naive, lactate-sensitive panic patients: a SPECT study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Basal ganglia phosphorous metabolism in chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Proton magnetic resonance spectroscopy of the medial prefrontal cortex in patients with deficit schizophrenia: preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: evidence for neuronal loss in the cingulate gyrus and the right striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

The hippocampus in patients treated with electroconvulsive therapy: a proton magnetic resonance spectroscopic imaging study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Effects of age, medication, and illness duration on the N-acetyl aspartate signal of the anterior cingulate region in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Phosphatidylcholine breakdown and signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Cortical pruning and the development of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Imaging as a tool in exploring the neurodevelopment and genetics of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

In vivo proton magnetic resonance spectroscopy of the medial temporal lobes of subjects with combat-related posttraumatic stress disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Myo-inositol in depressive and healthy subjects determined by frontal 1H-magnetic resonance spectroscopy at 1.5 tesla.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Heritability heightens brain metabolite differences in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Haloperidol improves membrane phospholipid abnormalities in temporal lobes of schizophrenic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Subtype-associated metabolite differences in the temporal lobe in schizophrenia detected by proton magnetic resonance spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Reductions in occipital cortex GABA levels in panic disorder detected with 1h-magnetic resonance spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Chemical mapping of anxiety in the brain of healthy humans: an in vivo 1H-MRS study on the effects of sex, age, and brain region.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Broadband decoupled, 1H-localized 13C MRS of the human brain at 4 Tesla.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

In vivo effects of adenosine A1 receptor agonist and antagonist on neuronal and astrocytic intermediary metabolism studied with ex vivo 13C NMR spectroscopy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Quantitative proton magnetic resonance spectroscopy of the basal ganglia in patients with affective disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Cerebral metabolism of lactate in vivo: evidence for neuronal pyruvate carboxylation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Brain kinetics of paroxetine and fluoxetine on the third day of placebo substitution: a fluorine MRS study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Measurements of human cerebral GABA at 4.1 T using numerically optimized editing pulses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Comparison of k-space sampling schemes for multidimensional MR spectroscopic imaging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Biochemical markers of intelligence: a proton MR spectroscopy study of normal human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Human brain fluoxetine concentrations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Fluoxetine and trifluoperazine in human brain: a 19F-nuclear magnetic resonance spectroscopy study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Magnetic resonance spectroscopy in affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Measurement of brain phosphoinositide metabolism in bipolar patients using in vivo 31P-MRS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Brain lithium concentration by 7Li- and 1H-magnetic resonance spectroscopy in bipolar disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Brain phosphorous metabolism in depressive disorders detected by phosphorus-31 magnetic resonance spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Alterations in brain phosphorous metabolism in bipolar disorder detected by in vivo 31P and 7Li magnetic resonance spectroscopy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Brain alcohol detectability increase with repeated administration in humans: a proton spectroscopy study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Cerebral phosphorus metabolite abnormalities in opiate-dependent polydrug abusers in methadone maintenance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Assessment of GABA concentration in human brain using two-dimensional proton magnetic resonance spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Hippocampal pathology in schizophrenia: magnetic resonance imaging and spectroscopy studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings--part II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Brain metabolic alterations in Cushing's syndrome as monitored by proton magnetic resonance spectroscopy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Applications of (7)Li NMR in biomedicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Topiramate increases cerebral GABA in healthy humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Neurochemical adaptation to cocaine abuse: reduction of N-acetyl aspartate in thalamus of human cocaine abusers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Alteration of brain phospholipid metabolites in cocaine-dependent polysubstance abusers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

In vivo proton magnetic resonance spectroscopy of alcohol in human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

An in vitro 1H nuclear magnetic resonance study of the temporoparietal cortex of Alzheimer brains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Regional metabolic alterations in Alzheimer's disease: an in vitro 1H NMR study of the hippocampus and cerebellum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Choline, myo-inositol and mood in bipolar disorder: a proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Lower levels of nucleoside triphosphate in the basal ganglia of depressed subjects: a phosphorous-31 magnetic resonance spectroscopy study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Lithium-induced increase in human brain grey matter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Case study: caudate glutamatergic changes with paroxetine therapy for pediatric obsessive-compulsive disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Proton magnetic resonance spectroscopy of the lenticular nuclei in bipolar I affective disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Proton magnetic resonance spectroscopy of lenticular nuclei in obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Proton magnetic resonance spectroscopy of lenticular nuclei in simple schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Effect of chronic psychosocial stress and long-term cortisol treatment on hippocampus-mediated memory and hippocampal volume: a pilot-study in tree shrews

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

The N-methyl-D-aspartate receptor, synaptic plasticity, and depressive disorder. A critical review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

31P nuclear magnetic resonance spectroscopy: neurodevelopment and schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

GABA and mood disorders: a brief review and hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Brain N-acetyl aspartate concentrations measured by H MRS are reduced in adult male rats subjected to perinatal stress: preliminary observations and hypothetical implications for neurodevelopmental disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Using pattern analysis of in vivo proton MRSI data to improve the diagnosis and surgical management of patients with brain tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Magnetic resonance spectroscopy guided brain tumor resection: differentiation between recurrent glioma and radiation change in two diagnostically difficult cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Lactate rise detected by 1H NMR in human visual cortex during physiologic stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

In vivo 7Li NMR diffusion studies in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Magnetic resonance spectroscopy of brain in epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Accumulation of fluoxetine and norfluoxetine in human brain during therapeutic administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Basal ganglia choline levels in depression and response to fluoxetine treatment: an in vivo proton magnetic resonance spectroscopy study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Changes in the 31P-NMR spectra of cats receiving lithium chloride systemically.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

In vivo measurement of lithium in humans by nuclear magnetic resonance spectroscopy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

In vivo nuclear magnetic resonance spectroscopy studies of the relationship between the glutamate-glutamine neurotransmitter cycle and functional neuroenergetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Variability of brain lithium levels during maintenance treatment: a magnetic resonance spectroscopy study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Brain proton magnetic resonance spectroscopy (1H-MRS) in Alzheimer's disease: changes after treatment with xanomeline, an M1 selective cholinergic agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Comparison of fMRI and PEPSI during language processing in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Frontal lobe membrane phospholipid metabolism and ventricle to brain ratio in schizophrenia: preliminary 31P-MRS and CT studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

High-energy phosphate metabolism in the frontal lobes of patients with panic disorder detected by phase-encoded 31P-MRS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Probable Alzheimer disease: diagnosis with proton MR spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Functional imaging studies: linking mind and basic neuroscience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Effects of lithium and amphetamine on inositol metabolism in the human brain as measured by 1H and 31P MRS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Brain lithium measurements with (7)Li magnetic resonance spectroscopy (MRS): a literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Brain lithium concentrations in bipolar disorder patients: preliminary (7)Li magnetic resonance studies at 3 T.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Fluoxetine: a serotonin-specific, second-generation antidepressant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Compounds containing cytosolic choline in the basal ganglia: a potential biological marker of true drug response to fluoxetine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings--part I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Erythrocyte choline concentration in bipolar disorder: a predictor of clinical course and medication response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Magnetization transfer of fluoxetine in the human brain using fluorine magnetic resonance spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

19F magnetic resonance spectroscopy investigation in vivo of acute and steady-state brain fluvoxamine levels in obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Towards a method for automated classification of 1H MRS spectra from brain tumours.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Dual voxel proton magnetic resonance spectroscopy in the healthy elderly: subcortical-frontal axonal N-acetylaspartate levels are correlated with fluid cognitive abilities independent of structural brain changes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Magnetic resonance spectroscopy and schizophrenia: what have we learnt?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Reduced phosphodiesters and high-energy phosphates in the frontal lobe of schizophrenic patients: a (31)P chemical shift spectroscopic-imaging study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

31P magnetic resonance spectroscopy in the frontal lobe of major depressed patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Frontal brain asymmetry as a biological substrate of emotions in patients with panic disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0

Proton magnetic resonance spectroscopy of the temporal lobes in schizophrenics and normal controls.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901313-0